SVB Leerink Upgrades Pacira Pharmaceuticals (PCRX) to Outperform
Tweet
Share
E-mailGet Alerts PCRX Hot Sheet
Price: $23.28 +0.43%
Rating Summary:
11 Buy, 16 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 11
Rating Summary:
11 Buy, 16 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 11
Join SI Premium – FREE
SVB Leerink analyst Ami Fadia upgraded Pacira Pharmaceuticals (NASDAQ: PCRX) from Market Perform to Outperform with a price target of $44.00 (from $46.00).
For an analyst ratings summary and ratings history on Pacira Pharmaceuticals click here. For more ratings news on Pacira Pharmaceuticals click here.
Shares of Pacira Pharmaceuticals closed at $32.52 yesterday.
You May Also Be Interested In
- New Street Research Upgrades Micron Technology (MU) to Buy
- Petronet LNG Ltd. (PLNG:IN) PT Raised to INR310 at ICICI Securities
- Indigo Paints (INDIGOPN:IN) PT Raised to INR1,300 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT Change, UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
